Pixium Vision, a bioelectronics company, agreed to acquire Second Sight Medical Products, a developer, manufacturer and marketer of implantable visual prosthetics. Financial terms were not disclosed. “Our planned business combination with Second Sight will bring exciting opportunities for both companies, given our synergistic business models and complementary presence in Europe and the U.S. Pixium Vision is well positioned to continue development of the promising Prima System: we have now launched the pivotal PRIMAvera study and have funding in place through the end of 2021. This transaction, including closing of the proposed financing, should provide us with sufficient resources to extend our cash runway beyond 2022, covering results from PRIMAvera," Lloyd Diamond, Pixium Vision CEO.